Bellevue Digital Health AI2

Reference Data

ISIN LU1916264945
Valor Number
Bloomberg Global ID
Fund Name Bellevue Digital Health AI2
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland Waystone Fund Services (Switzerland) SA
Lausanne
Phone: 0041213111781
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The Sub-fund is an actively managed equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and preference shares of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries.
Peculiarities

Fund Prices

Current Price * 155.80 USD 07.01.2026
Previous Price * 155.23 USD 06.01.2026
52 Week High * 156.73 USD 19.02.2025
52 Week Low * 124.11 USD 08.04.2025
NAV * 155.80 USD 07.01.2026
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 174,580,298
Unit/Share Assets ***
Trading Information SIX

Performance

YTD Performance +5.68% 31.12.2025
07.01.2026
YTD Performance (in CHF) +6.30% 31.12.2025
07.01.2026
1 month +2.22% 08.12.2025
07.01.2026
3 months +8.80% 07.10.2025
07.01.2026
6 months +5.93% 07.07.2025
07.01.2026
1 year +5.71% 07.01.2025
07.01.2026
2 years +15.42% 08.01.2024
07.01.2026
3 years +9.25% 09.01.2023
07.01.2026
5 years -33.40% 15.06.2021
07.01.2026

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Insulet Corp 6.93%
Intuitive Surgical Inc 5.56%
Penumbra Inc 5.56%
DexCom Inc 5.33%
Globus Medical Inc Class A 5.02%
Natera Inc 4.94%
Veeva Systems Inc Class A 4.49%
PROCEPT BioRobotics Corp 4.39%
Abbott Laboratories 4.38%
TransMedics Group Inc 4.20%
Last data update 30.11.2025

Cost / Risk

TER 1.38%
TER date 29.01.2021
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 0.80%
Ongoing Charges *** 1.31%
SRRI ***
SRRI date *** 30.11.2025

Breakdowns

Equity Countries ***

Equity Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)